HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - How long does it take to see a response to myeloma therapy?

Posted by
HealthTree Logo HealthTree
• May 8, 2026

Description

How long does it take to see a response to myeloma therapy?

On this video

Healthtree contact Shebli Atrash, MD, Specialist

Shebli Atrash, MD, Specialist

Levine Cancer Institute

Healthtree contact Beatrice M. Razzo, Specialist

Beatrice M. Razzo, Specialist

Jefferson Health Sidney Kimmel Comprehensive Cancer Center

Related Content

  • Event Navigating CAR-T Therapy: Understanding Side Effects and Staying Informed
  • Event Gather Community Event: Maintenance Therapy Basics & Peer Support for Newly Diagnosed Active Myeloma - NOT RECORDED
  • Video Brighter Days: Dawn's Autologous Stem Cell Transplant Experience
  • News Does Everyone Diagnosed with Multiple Myeloma Need A Stem Cell Transplant?
  • Event Standard of Care, CAR-T, and Bispecific Antibodies in Multiple Myeloma: A Research Roundtable on Patient Experiences an…
  • News Can Mezigdomide Help Elranatamab Work Better? Early Results From the MELT-MM Trial